Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002013930 | SCV002301663 | likely benign | not provided | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004046674 | SCV004955567 | uncertain significance | not specified | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.32A>G (p.E11G) alteration is located in exon 2 (coding exon 2) of the SPTA1 gene. This alteration results from a A to G substitution at nucleotide position 32, causing the glutamic acid (E) at amino acid position 11 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |